Progress in related genes of diabetic nephropathy

Chinese Pharmacological Bulletin

Volumn 24, Issue 11, 2008, Pages 1419-1422

  Yu, Min ^a   Zhou, Ilong Hao ^a   Liu, Zhao Qian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Diabetic nephropathy; Genetic polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADENOSINE TRIPHOSPHATASE (CALCIUM); ALDEHYDE REDUCTASE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR 1; CYSTATHIONINE BETA SYNTHASE; DIPEPTIDYL CARBOXYPEPTIDASE; HOMOCYSTEINE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ARTICLE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FAMILY HISTORY; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 60749098899     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Altshuler D, Hirschhorn J N, Klannemark M, et al. The common PPARgamma Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes[J]. Nat Genet, 2000,26(1):76-80.
2. ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes [J]. Diabetes, 2003, 52(2):568-72.
3. 2-adrenoceptor and obesity in hypertensive patients[J]. Chin Pharmacol Bull, 2006,22(2):154-9.
4. 3-adrenoceptor genetic polymorphism and diseases [J]. Chin Pharmacol Bull, 2005,21(12):1418-22.
5. 2+-ATPase activity in aortal vascular smooth muscle cells and aortic hemodynamics in rats during the development of diabetes [J]. Chin Pharmacol Bull, 2008,24(1):71-4.
6. Marre M, Jeunemaitre X, Gallosis Y, et al. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group[J]. J Clin Invest, 1997,99(7):1585-95.
7. Ohno T, Kawazu S, Tomono S. Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics[J]. Metabolism, 1996,45(2):218-22.
8. Wang Q, Ma Z X, Qiu S J. Association analyses of the polymorphism of angiolensin-converting enzyme gene with diabetic nephropathy[J]. Shandong Med J, 2007,47(26):71-2.
9. Buraczynska M, Ksiazck P, Lopatynski J, et al. Assosiation of the rennin-angiotensin system gene polymorphism with nephropathy in type 2 diabetes[J]. Pol Arch Med Wewn, 2002,108(2):725-30.
10. Guo M Q, Li L, Miao C, et al. Association analyses of the polymorphisms of angiotensin-converting enzyme gene and angiotensin II receptor-1 gene with diabetes[J]. Central China Med J, 2007,31 (1):25-7.
11. Wang Y, Ng M C, Lee S C, et al. Phenotypic heterogeneity and association of two aldose reduclase gene polymorphisms with nephropathy in type 2 diabetes [J]. Diabetes Care, 2003, 26(8): 2410-5.
12. Liu Y F, Wat N M, Chung S S, et al. Diabetic nephropathy is associated with the 5′-end dinucleotide repeat polymorphism of the aldose reductase gene in Chinese subjects with Type 2 diabetes[J] Diabet Med, 2002,19(2):113-8.
13. Wang W L, Yu D M, Liu D M. Association analyses of the 5′ end two polymorphisms of aldose reduclase gene with diabetic nephropathy [J]. Tianjin Med J, 2006,34(8):513-5.
14. Ksiazek P, Bednarek-Skublewska A, Buraczynska M. The C677T and methylenetetrahydrofolate reductase gene mutation nephropathy in type 2 diabetes mellitus[J]. Med Sci Monit, 2004,10(2):47-51.
15. Yoshioka K, Yoshida T, Takakum Y, et al. No association between the MTHFR gene polymorphism and diabetic retinopathy in type 2 diabetic patients without overt nephropathy[J]. Diabetes Care, 2003,26(6):1947-8.
16. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) assoiated with decreased enzyme activity[J]. Mol Genet Metab, 1998,64(3): 169-72.
17. Moczulski D, Fojcik H, Zukowska-Szczechowska E, et al. Effects of the C677T and A1298T polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy[J]. Nephrol Dial Transplant, 2003,18(8):1535-40.
18. Bennett G D, Wlodarczyk B, Calvin J A, et al. Valproic acid-induced alterations in growth and neurotrophic factor gene expression in murine embryos[J]. Reprod Toxicol, 2000,14(1):1-11.
19. Kitamura A, Hasegawa G, Obayashi H, et al. Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes[J]. Diabet Med, 2002, 19 (12):1000-5.
20. Wong T Y, Poon P, Chow K M, et al. Association of transforming growth factor-beta (TGF-beta) T869C (Leu10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese[J]. J Kidney Int, 2003,63(5):1831-5.
21. Eto M, Saito M, Okada M, et al. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients[J]. Am J Kidney Dis, 2002,40(2):243-51.